descriptionPublicationkeyboard_double_arrow_right Article 14 Mar 2016 English Publisher:CMA Joule Inc.Journal:Canadian Medical Association Journal, volume 188, pages 369.3-369 (issn: 0820-3946, eissn: 1488-2329,

Authors: Mariusz Gasior; Andrzej Lekston; Bartosz Hudzik;

doi: 10.1503/cmaj.1150087

pmid: 26977093

pmc: PMC4786396

NOACs: drug–drug interactions

- Summary
- Subjects
- Metrics

Abstract

We commend Fralick and colleagues for their article on drug interactions with rivaroxaban.[1][1] All novel oral anticoagulants (NOACs) were introduced as at least noninferior (in some cases superior) to warfarin. In addition to high efficacy, NOACs were reported to have a better safety profile with

Related Organizations

Medical University of Silesia
Poland
Silesian Center for Heart Disease
Poland

Keywords

Stroke, Atrial Fibrillation, Administration, Oral, Anticoagulants, Humans, Drug Interactions, Warfarin

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average